Yusri Elsayed
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Vascular Tumors and Angiosarcomas
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 25
- Peptidase Inhibition and Analysis 7
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 5
- CAR-T cell therapy research 5
- Hematology 22
- Multiple Myeloma Research and Treatments 13
- Co-authors
- Edward A. Sausville (5 shared papers)Manish Monga (3 shared papers)Margaret von Mehren (6 shared papers)Jean‐Yves Blay (5 shared papers)Claudia Lebedinsky (4 shared papers)Johann S. de Bono (3 shared papers)Brian L. Samuels (3 shared papers)Sant P. Chawla (2 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Blood (10 papers)Cancer Research (4 papers)Blood Advances (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
Yusri Elsayed
50 papers receiving 2.3k citations
Yusri Elsayed's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 1.1k
- Hematology 414
- Immunology 422
- Pulmonary and Respiratory Medicine 606
- Genetics 172
Countries citing papers authored by Yusri Elsayed
This map shows the geographic impact of Yusri Elsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusri Elsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusri Elsayed more than expected).
Fields of papers citing papers by Yusri Elsayed
This network shows the impact of papers produced by Yusri Elsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusri Elsayed. The network helps show where Yusri Elsayed may publish in the future.
Co-authors
The 25 scholars most cited alongside Yusri Elsayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules Hit paper breakdown → | 2009 | 397 |
| 2 | 2005 | 344 | |
| 3 | Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer Hit paper breakdown → | 2012 | 336 |
| 4 | 2020 | 115 | |
| 5 | 2009 | 112 | |
| 6 | 2013 | 97 | |
| 7 | 2005 | 93 | |
| 8 | 2020 | 90 | |
| 9 | 2011 | 81 | |
| 10 | 2003 | 75 | |
| 11 | 2008 | 62 | |
| 12 | 2016 | 47 | |
| 13 | 2001 | 44 | |
| 14 | 2009 | 40 | |
| 15 | 2020 | 38 | |
| 16 | 2011 | 37 | |
| 17 | 1996 | 36 | |
| 18 | 2020 | 35 | |
| 19 | 2007 | 31 | |
| 20 | 2022 | 30 |
About Yusri Elsayed
Yusri Elsayed is a scholar working on Oncology, Hematology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 51 papers that have together received 2.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Peptidase Inhibition and Analysis (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Sarcoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (1.1k citations), Hematology (414 citations), Immunology (422 citations), Pulmonary and Respiratory Medicine (606 citations) and Genetics (172 citations). Yusri Elsayed has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Edward A. Sausville, Manish Monga, Margaret von Mehren, Jean‐Yves Blay, Claudia Lebedinsky, Johann S. de Bono, Brian L. Samuels, Sant P. Chawla, Scott M. Schuetze and Axel Le Cesne. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Blood Advances and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.